PreClinical CRO dedicated to your NonClinical projects
NEWS
Syncrosome at the 7th Microdialysis Symposium 2013 The Central Nervous System department is involved in Blood Brain barrier passage experiments since 10 years now. CSF sampling and Microdialysis are 2 important tools used to evaluate the kinetics of Candidate Compounds but also their action on the Neurotransmitters |
Syncrosome at the 2013 BioChicago Congress Richard Mitry, CEO of Syncrosome, attended the Biochicago Congress last month in United-States. |
Meet Syncrosome during Biotrinity congress As you know SYNCROSOME is a Preclinical Drug Evaluation Company specialised in human health. Since 2000, Syncrosome is mainly focused on in vivo efficacy studies dedicated to discovery and preclinical stage with more than 25 animals models, to provide you the right data to make the right decision. |
Animal models of Inflammatory Bowel Disease (IBD)? Inflammatory Bowel Disease (IBD) is a generic term that covers a range of disease including Ulcerative Colitis (UC) and Crohn's Disease (CD) for which there is still no cure. |
DRUG EVALUATION SERVICES:
How can I find the information I am looking for?
To have a overview of our services go to the homepage.
More detailled information in the sub pages of "drug evaluation services":
- Drug efficacy
- In Vivo pharmacokinetics
- Safety assessment
We can provide you with a combinated form of these studies for example
- Efficacy and early safety in the same experiment.
- Efficacy and Pharmacokinetics: advanced PK/PD.
- Safety and Pharmacokinetics: DMPK.
The main objective of combined studies is to improve scientific relevance by analysing the safety and pharmacokinetics aspects of your compounds on the same species which has been used for efficacy.
Combined studies allow for a reduction in the number of animal subjects used.
The final benefit of combined studies is to optimize the use of your budget!